What is the appropriate management of migraine headaches during the second trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Migraine in Second Trimester of Pregnancy

For acute treatment of migraine in the second trimester, NSAIDs (specifically ibuprofen) should be used as first-line therapy, with acetaminophen as an alternative if NSAIDs are contraindicated; triptans (particularly sumatriptan) may be considered under specialist supervision if first-line options fail. 1

Acute Treatment Approach

First-Line Options

  • NSAIDs are uniquely permissible during the second trimester only and represent the optimal acute treatment choice during this specific window of pregnancy 1
  • Ibuprofen is the preferred NSAID based on safety data 2
  • Critical caveat: NSAIDs must be discontinued before entering the third trimester due to risks of premature closure of the ductus arteriosus and other fetal complications 1, 2

Alternative First-Line Treatment

  • Acetaminophen (paracetamol) remains safe throughout all trimesters but has relatively poor efficacy for migraine 1, 2
  • Should be used when NSAIDs are contraindicated or if patient preference dictates 3

Second-Line Options

  • Triptans, particularly sumatriptan, should only be used under strict specialist supervision given limited safety data derived primarily from post-marketing surveillance 1
  • Recent systematic review evidence suggests triptans may not be associated with fetal/child adverse effects (low strength of evidence), making them reasonable second-line options when first-line treatments fail 4
  • Sumatriptan has the most extensive safety data among triptans 2

Adjunctive Treatment for Nausea

  • Metoclopramide can be used for migraine-associated nausea during pregnancy 1
  • Combination metoclopramide plus diphenhydramine may be more effective than codeine for migraine treatment (though this evidence is not pregnancy-specific) 4

Preventive Treatment Considerations

General Principle

  • Preventive medications are best avoided during pregnancy due to potential fetal harm 1
  • Should only be considered when migraine attacks are frequent and significantly disabling despite optimized acute treatment 1

If Preventive Treatment is Clinically Necessary

  • Propranolol has the best available safety data and is the preferred preventive agent if treatment cannot be avoided 1, 3
  • Amitriptyline may be used if propranolol is contraindicated 1
  • Both require specialist supervision with careful monitoring for potential fetal harm 1

Absolutely Contraindicated Preventive Agents

  • Sodium valproate is absolutely contraindicated - known teratogen that must never be used 1
  • Topiramate is contraindicated due to adverse fetal effects 1
  • Candesartan is contraindicated due to fetal risks 1

Non-Pharmacological Approaches

  • Should be prioritized as first-line management before any medication 5, 6
  • Include lifestyle modifications, trigger avoidance, adequate hydration, regular sleep patterns, and stress management 5, 6
  • Behavioral therapies should complement any required pharmacological treatment 2

Clinical Context

  • Migraine often improves during the second and third trimesters in more than half of affected women, particularly those with menstrual migraine or migraine without aura 5
  • Women with migraine with aura may experience worsening symptoms and face increased risk of pregnancy complications including preeclampsia and stroke, warranting closer monitoring 6
  • The second trimester represents a unique therapeutic window where NSAIDs can be safely utilized before third-trimester restrictions apply 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.